Navigation Links
Animal food allergens unmasked
Date:10/14/2007

The relatedness of an animal food protein to a human protein determines whether it can cause allergy, according to new research by scientists from the Institute of Food Research in Norwich and the Medical University of Vienna.

In theory all proteins have the potential to become allergens, but the study found that in practice the ability of animal food proteins to act as allergens depends on their evolutionary distance from a human equivalent.

This explains why people who are allergic to cows milk can often tolerate mares milk but not goats milk, said Dr Clare Mills of the Institute of Food Research. Proteins in horse milk are up to 66% identical to human milk proteins, while known allergens from cows and goats are all less than 53% identical to corresponding human proteins.

Overall we found that only an animal food protein that is less than 54% identical to a human equivalent could become allergenic.

Cows milk and hens eggs are common causes of allergy in infants, while the most common animal food allergens in adults are fish and seafood.

For the first time the researchers found that the majority of animal food allergens could be classified into one of three protein families. Tropomyosins, proteins found in muscle tissue, are the most important family.

Tropomyosins in mammals, fish and birds are at least 90% identical to at least one human tropomyosin and none have been reported to be allergenic. In contrast, the allergenic tropomyosins are all from invertebrates such as insects, crustaceans and nematodes and at most are only 55% identical to the closest human homologue, said Dr Heimo Breiteneder of the Medical University of Vienna.

EF-hand proteins form the second largest animal food allergen family. Those in birds and mammals are not allergenic, while those in frogs and fish can cause allergy. The third animal food allergen family, caseins, are all mammalian proteins from milk. The researche
'/>"/>

Contact: Zoe Dunford
zoe.dunford@bbsrc.ac.uk
44-016-032-55111
Norwich BioScience Institutes
Source:Eurekalert

Page: 1 2

Related biology news :

1. Plants, animals share molecular growth mechanisms
2. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
3. Study Links Ebola Outbreaks To Animal Carcasses
4. Scientists rid stem cell culture of key animal cells
5. Elephants imitate truck noises, other animals
6. UCSD researchers maintain stem cells without contaminated animal feeder layers
7. Gene Therapy For Parkinsons Disease Moves Forward In Animals
8. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals
9. Gene therapy for Parkinsons disease moves forward in animals
10. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
11. Flocking together: Study shows how animal groups find their way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... Feb. 9, 2015  Lintec of America recently announced ... carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, ... Leveraging the vast industrial resources of the ... , Lintec of America is forming the Nano-Science ... , focusing on scaling up the manufacturing and ...
(Date:2/5/2015)... OXFORD, Conn. , Jan. 26, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... a new corporate website ( http://www.nxt-id.com/ ) as part ... Wocket™ smart wallet. The Company launched its new consumer ... Gino Pereira , CEO of NXT-ID said, "Our ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... that it will expand urea deep placement (UDP)a technology that ... hectares (ha) of rice land, reaching about 1.6 million farm ... UDP is the insertion of large urea briquettes into the ... Farmers who use UDP can increase yields by 25% while ...
... of Vanderbilt researchers have demonstrated for the first time ... interference, can heal a genetic disorder in a live ... by the journal Endocrinology, shows that RNA interference can ... engineered to express a defective human hormone that interferes ...
... most successful invasive species in the world, having colonized parts ... South America. A new study sheds light on the secrets ... University of Illinois and the University of California at San ... Academy of Sciences. The Argentine ant is tiny, aggressive ...
Cached Biology News:Bangladesh to dramatically expand technology that doubles efficiency of urea fertilizer use 2RNA interference therapy heals growth deficiency disorder in a live animal 2RNA interference therapy heals growth deficiency disorder in a live animal 3RNA interference therapy heals growth deficiency disorder in a live animal 4Ant invaders eat the natives, then move down the food chain 2
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... de Paris in December 2011, ... study of yttrium-90 resin microspheres versus sorafenib in advanced ... results expected late 2016.   SARAH, a ... liver cancer (hepatocellular carcinoma, or HCC) has completed patient ...
(Date:3/3/2015)... 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, TSX: ... diagnostics that target the underlying mechanisms of cancer, today ... ended December 31, 2014. Effective July 17, ... May 31 to December 31. As a result of ... for the quarter and the seven months ended December ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Osprey Pharmaceuticals U.S.A., a,privately-held company focused on ... leukocytes that are responsible,for initiating and maintaining ... raised $11 million in its first round ... by Burrill & Company with participation from,Novo ...
... NORTH BRUNSWICK, N.J. and NANJING, China, Sept. 3 ... strategic,alliance, combining the drug discovery expertise and project ... medicinal chemistry resources and,favorable cost structure of Acesys ... the alliance will encompass all,aspects of medicinal chemistry ...
... PPHM ) today announced that it will release,its ... 2009 on,September 9, 2008 at 7:00 a.m. EDT and ... results at 11:30 a.m. EDT on the same day., ... the,first quarter ended July 31, 2008 and will review ...
Cached Biology Technology:Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 2Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing 3Acesys and Provid Announce Alliance for Medicinal Chemistry Services 2Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results 2